BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 8403814)

  • 1. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C; Brosius FC; Palmieri J
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP
    J Nephrol; 1999; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C; Passerini P
    Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
    Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
    Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
    Zietse R; Weimar W
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1749-53. PubMed ID: 1407123
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
    Stiles KP; Abbott KC; Welch PG; Yuan CM
    Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the nephrotic syndrome with cyclosporin A.
    Ponticelli C
    J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rarity of minimal change disease in Nigerian patients with the nephrotic syndrome.
    Kadiri S; Osobamiro O; Ogunniyi J
    Afr J Med Med Sci; 1993 Dec; 22(4):29-34. PubMed ID: 7839926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A; Simon P
    Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome in adults: diagnosis and management.
    Kodner C
    Am Fam Physician; 2009 Nov; 80(10):1129-34. PubMed ID: 19904897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.